These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35487270)

  • 1. Cytokine profile and cholesterol levels in patients with Niemann-Pick type C disease presenting neurological symptoms: in vivo effect of miglustat and in vitro effect of N-acetylcysteine and coenzyme Q10.
    Hammerschmidt TG; Donida B; Faverzani JL; Moura AP; Dos Reis BG; Machado AZ; Kessler RG; Sebastião FM; Reinhardt LS; Moura DJ; Vargas CR
    Exp Cell Res; 2022 Jul; 416(2):113175. PubMed ID: 35487270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial in vitro effect of N-acetylcysteine and coenzyme Q10 on DNA damage in neurodegenerative Niemann-Pick type C 1 disease: preliminary results.
    Hammerschmidt TG; Guerreiro GB; Donida B; Raabe M; Kessler RG; Ferro MB; Moura DJ; Giugliani R; Vargas CR
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1563-1569. PubMed ID: 36795166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
    Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
    Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early miglustat therapy in infantile Niemann-Pick disease type C.
    Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
    Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year.
    Chien YH; Lee NC; Tsai LK; Huang AC; Peng SF; Chen SJ; Hwu WL
    J Inherit Metab Dis; 2007 Oct; 30(5):826. PubMed ID: 17603755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
    Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
    Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
    Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
    Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.
    Patterson MC; Vecchio D; Prady H; Abel L; Wraith JE
    Lancet Neurol; 2007 Sep; 6(9):765-72. PubMed ID: 17689147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients.
    Hammerschmidt TG; de Oliveira Schmitt Ribas G; Saraiva-Pereira ML; Bonatto MP; Kessler RG; Souza FTS; Trapp F; Michelin-Tirelli K; Burin MG; Giugliani R; Vargas CR
    Int J Dev Neurosci; 2018 May; 66():18-23. PubMed ID: 29197565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miglustat: a review of its use in Niemann-Pick disease type C.
    Lyseng-Williamson KA
    Drugs; 2014 Jan; 74(1):61-74. PubMed ID: 24338084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
    J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.
    Stein VM; Crooks A; Ding W; Prociuk M; O'Donnell P; Bryan C; Sikora T; Dingemanse J; Vanier MT; Walkley SU; Vite CH
    J Neuropathol Exp Neurol; 2012 May; 71(5):434-48. PubMed ID: 22487861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in Niemann-Pick disease, type C.
    Fu R; Yanjanin NM; Bianconi S; Pavan WJ; Porter FD
    Mol Genet Metab; 2010; 101(2-3):214-8. PubMed ID: 20667755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
    Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
    Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat.
    Fecarotta S; Amitrano M; Romano A; Della Casa R; Bruschini D; Astarita L; Parenti G; Andria G
    Am J Med Genet A; 2011 Mar; 155A(3):540-7. PubMed ID: 21344635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
    Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
    Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
    Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
    J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of redox imbalance and mitochondrial dysfunction in Niemann-Pick type C 1 patients: the in vitro effect of combined therapy with antioxidants and β-cyclodextrin nanoparticles.
    Hammerschmidt TG; Donida B; Raabe M; Faverzani JL; de Fátima Lopes F; Machado AZ; Kessler RG; Reinhardt LS; Poletto F; Moura DJ; Vargas CR
    Metab Brain Dis; 2023 Feb; 38(2):507-518. PubMed ID: 36447062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.